The benefits of a prostate cancer screening tool

October 07, 2020

Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its availability, detection relied on clinical exams and prostate specific antigen screening.

In a study published in investigators found that the availability of mpMRIp in Australia since 2012 has correlated with significantly reduced numbers of prostate biopsies by an average of 354.7 per month, with an estimated annual saving of $13.2 million.

"Our research shows publically funded prostate MRI not only represents good policy in terms of health equity, but it also makes sense from a financial perspective," said lead author Thomas Whish-Wilson, BBiomedSc, MD, of St Vincent's Hospital Melbourne and The University of Melbourne, in Australia.
-end-


Wiley

Related Prostate Articles from Brightsurf:

The benefits of a prostate cancer screening tool
Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its availability, detection relied on clinical exams and prostate specific antigen screening.

Prostate cancer: How can we decide when to treat?
You have been diagnosed with prostate cancer and your doctor gives you the option of not being treated, but of remaining under observation: is there any objective way you can decide to be treated or not treated?

AI can be used to detect and grade prostate cancer
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence for histopathological diagnosis and grading of prostate cancer.

Men taking medications for enlarged prostate face delays in prostate cancer diagnosis
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.

Laser-targeted removal of prostate tumors works as well complete removal of prostate
Researchers from The University of Texas Medical Branch at Galveston, led by prostate cancer treatment pioneer Dr.

How prostate cancer becomes treatment resistant
Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified how prostate cancer transforms into a deadly treatment-resistant prostate cancer subtype called neuroendocrine prostate cancer (NEPC) following treatment with anti-androgen therapy.

Surgery unnecessary for many prostate cancer patients
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it.

ALS drug may help treat prostate cancer
Researchers have discovered a new use for an old drug as a potential treatment for prostate cancer.

Study paves the way for better treatment of prostate cancer
A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.

Distress in men following prostate cancer can be reduced
A new web-based support program will help reduce the psychological stress that impacts men who are recovering from prostate cancer.

Read More: Prostate News and Prostate Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.